A detailed history of Cullen/Frost Bankers, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 3,600 shares of GMED stock, worth $294,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,600
Previous 3,600 -0.0%
Holding current value
$294,408
Previous $246,000 4.47%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$52.61 - $59.54 $68,393 - $77,402
-1,300 Reduced 26.53%
3,600 $214,000
Q4 2021

Feb 07, 2022

SELL
$62.62 - $79.92 $28,304 - $36,123
-452 Reduced 8.45%
4,900 $354,000
Q2 2021

Aug 05, 2021

BUY
$61.85 - $77.53 $27,956 - $35,043
452 Added 9.22%
5,352 $415,000
Q4 2019

Feb 06, 2020

BUY
$49.45 - $59.5 $242,305 - $291,550
4,900 New
4,900 $289,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.3B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.